Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

Within brain health, the robust demand for AD-detect blood tests for assessing Alzheimer's disease risk drives solid growth ...

I started as a Route Service Representative back in March 1984 at a small lab in Cambridge, Massachusetts called Spectrum ...

The stock's fall snapped a two-day winning streak.

Quest Diagnostics Inc. hit a new 52-week high, surpassing its previous peak of $168.17, which the company achieved on February 11th.

NORTHAMPTON, MA / ACCESS Newswire / February 13, 2025 / I started as a Route Service Representative back in March 1984 at a small lab in Cambridge, Massachusetts called Spectrum Medical Labs as one of ...

Grail (GRAL) stock shot up 33% Thursday, the day after the company announced a partnership with Quest (DGX) to expand ...

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by investment analysts at UBS Group from $166.00 ...

State of Alaska Department of Revenue reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 32.6 ...

Highlights,Quest Diagnostics, (NYSE:DGX),has seen an increase in institutional ownership, with various firms adjusting their ...

Quest Diagnostics (NYSE:DGX), a leader in diagnostic testing and information services, released its fourth quarter results on ...